12 May 2022 Online / Webex
8 am PDT / 11 am EDT / 5 pm CEST
Outline
- Discover how new drugs are triggering the development of large volume injection devices
- How Ypsomed and SCHOTT combine and apply their expertise to a new injection device
- Participate in the live Q&A session with our experts
(Subscription closed)
Speakers
Reto Jost – Speaker
Reto Jost is Innovation & Business Development Director at Ypsomed Delivery Systems. He started at Ypsomed in 2014 and assumed several roles in product management and business development, working with pharma companies to develop and bring to market innovative self-injection systems. Since 2018 his main focus is on new product innovation and in particular large-volume injections.
Felix Brosi – Speaker
Felix Brosi studied chemistry before he obtained his PhD in inorganic chemistry from the Freie Universität Berlin, Germany. In May 2017, he joined the Scientific Services and Product Management team of SCHOTT AG. Today, he works as Global Product Manager cartridges at SCHOTT AG.
Ian Thompson – Moderator
Ian Thompson is Vice President Business Development and has been with Ypsomed since 1995. He studied biochemistry and biotechnology. Since 2003 his main focus has been business development and new product innovation leading to the successful development and launch of a range of new pen, autoinjector and patch injector systems.
